Gan & Lee Pharmaceuticals (Shanghai Stock Exchange: 603087) is a Chinese biopharmaceutical company founded in 1998, specializing in the research, development, production, and commercialization of recombinant insulin analogs and injection devices for diabetes care, alongside a growing oncology pipeline and medical devices. - View it on GitHub